Document Classification

Section Type: RESULTS

Text: On Day 3 of the trial (1) IPSS improvement was significantly greater with DOX GITS than with placebo ; (2) proportion of patients with > or = 30 % improvement in IPSS was significantly greater with DOX GITS (49. 5 %) than placebo (28. 4 %) and remained so through Day 14 ; (3) improvement in Q (max) was significantly greater with DOX GITS (3. 7 mL/s) than placebo (1. 9 mL/s) and remained so through Day 14 ; (4) proportion of patients with > or = 3 mL/s increase in Q (max) was statistically greater with DOX GITS (54. 4 %) versus placebo (30. 8 %) and remained so through Day 14.